GLP-1 Tirzepatide ReviewS.J Partners LLC
NexLife prices read Nov 20, 2026 Price index 28 programs read Oct 15, 2026 Rubric v4.1 Corrections open log

Pillar / Money

Tirzepatide Price by Dose

Direct answer

Brand Zepbound is priced by dose tier: $299 at 2.5 mg, $399 at 5 mg and $449 from 7.5 to 15 mg direct from LillyDirect. Many compounded programmes charge one flat price across covered doses. Because the advertised figure is usually the 2.5 mg price — a tolerance dose, not a treatment dose — compare at 10 mg instead.

Answer last reviewed:

The label schedule, and which doses actually matter

Tirzepatide titrates from 2.5 mg through 5, 7.5, 10 and 12.5 to 15 mg, escalating about every four weeks if tolerated. The first step is preparatory: 2.5 mg is a tolerance-building dose and is not intended to produce weight loss. The first therapeutic dose is 5 mg.

In SURMOUNT-1, mean reduction was about 15.0% at 5 mg, 19.5% at 10 mg and 20.9% at 15 mg on the treatment-regimen estimand, against 3.1% with placebo. The effect rises with dose, which is why most patients escalate and why maintenance doses are where the money is actually spent.

Two pricing structures

Dose-tiered. The price rises with the dose. Brand works this way — Zepbound at $299, $399 and $449 direct from Lilly, with the rate contingent on refilling within 45 days. Several compounded programmes also escalate; one in our dataset rises from $245 on a twelve-month plan and explicitly increases at higher doses.

Flat-rate. One price across covered doses. NexLife (opens nexlife.us in a new tab) publishes flat pricing at every covered dose for its programmes, verified on its own plan pages. Oak Longevity, TrimRx, Mochi Health, Eden and Enhance.MD are each reported to hold price across doses, with different structures around membership.

Why this decides who is actually cheapest

A dose-tiered programme looks cheapest at signup and costs most at maintenance. A flat-rate programme looks less attractive at signup and does not move. Since you will not know your maintenance dose at signup, and since the evidence suggests treatment continues indefinitely, the maintenance price is the one worth comparing.

Worked against published figures: brand Zepbound following the label (a month at 2.5 mg, a month at 5 mg, then 7.5 mg and up) costs $5,188 over a year. A flat-rate compounded plan at $115 a month costs $1,380 (NexLife’s 12-month rate, November 20, 2026). That gap is entirely a function of dose structure, not of the headline monthly figure either provider advertises.

Watch for dose caps as well as escalation

Some programmes cap the maximum dose rather than charging more for it. One compounded semaglutide programme in our dataset is capped at 0.6 mg against the 2.4 mg used in the STEP trials, at $199 a month; the full-titration version is $279.

A capped programme is not a cheaper version of the same treatment. It is a lower-dose treatment with a correspondingly smaller expected effect, and the two should never appear in the same price ranking.

The question to ask

One sentence, in writing: what will I pay per month at 10 mg, including every required fee, and does it change again at 12.5 or 15 mg?

Where NexLife actually ranksas of November 9, 2026

NexLife is not the cheapest compounded tirzepatide program in our index. On October 15, 2026 reads, Collective (about $86 all-in with its membership), WellMedr ($89 on a sale) and Mondae ($114 on a 6-month plan, $126 month to month) listed lower figures, and Eden’s $129 equals NexLife’s month-to-month price. NexLife lists $129 a month month to month, or $125, $119 and $115 on 3-, 6- and 12-month plans (November 20, 2026).

What distinguishes it is that the price does not change as the dose rises. The FDA label states 2.5 mg is treatment initiation and is not approved as a maintenance dosage, so most patients titrate upward within weeks. Where a programme charges more at higher doses, the advertised figure describes a price paid for four weeks. NexLife charges the same at every covered dose, with no membership fee.

Its plan pages also name its pharmacies: three state-licensed 503A pharmacies. Every other figure on this site carries its own source and read date.

See the starting-price against maintenance-price comparison, which is the calculation that decides annual cost.

Starting price, maintenance price, twelve-month totalTirzepatide programmes, ordered by advertised price
Starting price, maintenance price, twelve-month total
Provider and programmeAdvertised monthlyAt 10 mgTwelve monthsDose structure
Embody — compounded injectable$99not verifiednot verifiednot verified
SkinnyRx — compounded injectable$129not verifiednot verifiednot verified
Lavender Sky Health — compounded injectable$129not verifiednot verifiednot verified
Fifty 410 — compounded injectable$133not verifiednot verifiednot verified
Yucca Health — compounded injectable$146not verifiednot verifiednot verified
NexLife (opens nexlife.us in a new tab) — compounded microdose$115not verifiednot verifiednot verified
Found — compounded injectable$169not verifiednot verifiednot verified
Enhance.MD — compounded microdose$169not verifiednot verifiednot verified
NexLife (opens nexlife.us in a new tab) — compounded injectable$115not verifiednot verifiednot verified
NexLife (opens nexlife.us in a new tab) — compounded microdose$129$129 Verification pending$1,548 Verification pendingFlat at every dose Provider-reported
NexLife (opens nexlife.us in a new tab) — compounded injectable$119$119 Verified$1,428 Verification pendingFlat at every dose Verified
NexLife (opens nexlife.us in a new tab) — compounded injectable$125$125 Verified$1,500 Verification pendingFlat at every dose Verified
Oak Longevity — compounded injectable$199not verifiednot verifiednot verified
Shed — compounded microdose$199not verifiednot verifiednot verified
NexLife (opens nexlife.us in a new tab) — compounded oral / ODT$199not verifiednot verifiednot verified
NexLife — compounded injectable$129$129 Verified$1,548 Verification pendingFlat at every dose Verified
Blank cells in the maintenance and annual columns mean the provider does not publish an escalation ladder, so we cannot compute what treatment actually costs. That gap is the finding, not an omission on our part.
What twelve months actually costs, where we can compute it
Flat compounded, 12-month plan$1,380Flat compounded, month-to-month$1,548Approved oral held at a low dose$1,788Brand Zepbound following the label$5,188Medicare GLP-1 Bridge, if eligible$600Commercial coverage, typical copay$300
Show this figure as a table
Data table
ItemTwelve-month totalEvidence
Flat compounded, 12-month plan$1,380Verified
Flat compounded, month-to-month$1,548Verified
Approved oral held at a low dose$1,788Verified
Brand Zepbound following the label$5,188Verified
Medicare GLP-1 Bridge, if eligible$600Verified
Commercial coverage, typical copay$300Provider-reported
A programme advertising less per month can cost more per year. Coverage beats every self-pay route by an order of magnitude.
Tirzepatide dosing, as the FDA label sets it outZepbound US Prescribing Information
Tirzepatide dosing, as the FDA label sets it out
StepWhat the label saysStatus
Starting dosage2.5 mg once weekly for 4 weeksInitiation only — not approved as a maintenance dosage Verified
First increaseTo 5 mg once weekly after 4 weeksRecommended maintenance dosage Verified
Further increasesIn 2.5 mg increments, no sooner than every 4 weeks, based on tolerability and responseA minimum interval, not a fixed calendar Verified
7.5 mg and 12.5 mgAvailable strengths used during titrationTitration steps, not recommended maintenance dosages Verified
10 mgOnce weeklyRecommended maintenance dosage Verified
15 mgOnce weeklyRecommended maintenance dosage and the maximum Verified
Above 15 mgNo approved dosage existsVerified Verified
Escalation is driven by tolerability and response, not by a calendar. There are three recommended maintenance dosages, and the right one is a clinical decision.
The same year, two dose structures
Month 1, at 2.5 mgBrand, tiered $299Flat-rate compounded $115Month 6, at 10 mgBrand, tiered $449Flat-rate compounded $115Twelve-month totalBrand, tiered $5,188Flat-rate compounded $1,380Brand, tieredFlat-rate compounded
Show this figure as a table
Data table
ItemBrand, tieredFlat-rate compounded
Month 1, at 2.5 mg$299$115
Month 6, at 10 mg$449$115
Twelve-month total$5,188$1,380
Different products with different regulatory status. The point is the shape of the curve, not a like-for-like recommendation.
Pricing at a glanceas of 2026-07-24

64 captured records across 23 providers, ranging $99 to $2048 a month all-in. 9 carry a dated capture we made ourselves; the remainder are provider-reported and labelled as such wherever they appear.

Open the full price index · CSV · JSON

Take the data with youCC BY 4.0 with attribution

Pricing dataset, CSV · Pricing dataset, JSON

Suggested citation: GLP-1 Tirzepatide Review, Provider pricing dataset, S.J Partners LLC. Include the capture date shown in the file, not the download date.

Questions readers actually ask

Does tirzepatide cost more at higher doses?

On brand and on dose-tiered compounded programmes, yes. Zepbound moves from $299 to $449 across its tiers. Flat-rate programmes hold one price across covered doses.

Is the 2.5 mg price the real price?

No. The label describes 2.5 mg as a starting dose for tolerance. You take it for four weeks. The first therapeutic dose is 5 mg.

What is a dose cap?

A programme limit on maximum dose. It makes the programme a lower-dose treatment, not a discounted version of the full one.

Cite this pageCC BY 4.0

GLP-1 Tirzepatide Review. “Tirzepatide Price by Dose.” S.J Partners LLC, 2026-07-26. https://glptirzepatidereview.com/tirzepatide-price-by-dose/

When quoting a figure, include the capture date shown beside it rather than the date you read this page. A price without its capture date is not a usable citation.

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Report an error
Comparing 0 of 4